Yield10 posts $14.5M net loss in 2023; licenses Camelina to Vision for $3M

YIELD10 BIOSCIENCE, INC.

2024-Q1 EPS reported -$4.77 revenue$300,000

Full-year 2023 net loss $14.5M ($1.82/share) vs $13.6M ($2.76/share) in 2022.
Ended 2023 with $1.1M cash; used $10.1M in operations; raised $1.2M net via warrant inducement in Mar 2024.
Granted Vision Bioenergy global license for Camelina biofuel feedstock; $3M cash payments for license.
USDA-APHIS cleared omega-3 traits; CFIA cleared E3902 (oil yield +5%) for planting in Canada.
Omega-3 Camelina targeted for aquafeed; potential revenue as early as 2025.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.8

YIELD10 BIOSCIENCE, INC. reported financial results for the fourth quarter and full year ended December 31, 2023.

Period: the fourth quarter and full year ended December 31, 2023
Result: reported results

Exact text from the filing

On April 1, 2024 , Yield10 Bioscience, Inc. issued a press release announcing the financial results for the quarter and fiscal year ended December 31, 2023.

View on SEC.gov

324 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR

accession 0001121702-24-000019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.